ALACHUA, Fla., February 3, 2025 – Evergen ("the Company"), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback